688488 Stock Overview
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Jiangsu Aidea Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.78 |
| 52 Week High | CN¥17.40 |
| 52 Week Low | CN¥9.63 |
| Beta | 0.47 |
| 1 Month Change | -11.66% |
| 3 Month Change | 38.13% |
| 1 Year Change | 8.68% |
| 3 Year Change | -20.88% |
| 5 Year Change | n/a |
| Change since IPO | -52.20% |
Recent News & Updates
Shareholder Returns
| 688488 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -4.9% | 4.3% | 2.9% |
| 1Y | 8.7% | -21.4% | -13.2% |
Return vs Industry: 688488 exceeded the CN Biotechs industry which returned -21.4% over the past year.
Return vs Market: 688488 exceeded the CN Market which returned -13.2% over the past year.
Price Volatility
| 688488 volatility | |
|---|---|
| 688488 Average Weekly Movement | 7.4% |
| Biotechs Industry Average Movement | 7.8% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 688488's share price has been volatile over the past 3 months.
Volatility Over Time: 688488's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 476 | Heliang Fu | www.aidea.com.cn |
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.
Jiangsu Aidea Pharmaceutical Co., Ltd. Fundamentals Summary
| 688488 fundamental statistics | |
|---|---|
| Market cap | CN¥6.22b |
| Earnings (TTM) | -CN¥90.16m |
| Revenue (TTM) | CN¥391.64m |
15.9x
P/S Ratio-69.0x
P/E RatioIs 688488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688488 income statement (TTM) | |
|---|---|
| Revenue | CN¥391.64m |
| Cost of Revenue | CN¥236.14m |
| Gross Profit | CN¥155.50m |
| Other Expenses | CN¥245.66m |
| Earnings | -CN¥90.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 39.70% |
| Net Profit Margin | -23.02% |
| Debt/Equity Ratio | 40.3% |
How did 688488 perform over the long term?
See historical performance and comparison